Discharge Counseling and Medication Therapy Management (MTM) Services After Discharge for Heart Failure Patients
NCT ID: NCT01822171
Last Updated: 2013-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
1 participants
INTERVENTIONAL
2013-01-31
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reducing 30-day Readmissions in Patients With Heart Failure Through Pharmacist Discharge Medication Services
NCT02752997
Post-Discharge Follow-Up Phone Call by a Pharmacist and Impact on Patient Care
NCT00332514
Ambulatory Medication Reconciliation Following Hospital Discharge
NCT00740675
Improving Safety After Hospitalization in Older Persons on High-Risk Medications
NCT02781662
Optimizing Medication Therapy for Patients Recently Discharged From Hospital
NCT02888782
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Discharge counseling and MTM follow-up
At the time of hospital discharge the subject will receive:
* Discharge medication counseling from a pharmacist
* Home medication if needed
* Approximately 7 days after hospital discharge the subject have a Follow-up visit at Medication Therapy Management clinic.
Discharge medication counseling from a pharmacist
Patient will be educated about proper dosing instructions, potential side effects, and when to recontact the treating physician office.
Home medication if needed
Patient will be provided with medication to take home, when needed.
Follow-up visit at Medication Therapy Management clinic
This comprehensive Medication Therapy Management clinic follow-up visit is scheduled for 7 days post hospital discharge. The approximately 1 hour visit is scheduled with a pharmacist to review current drug therapy and make recommendations, if needed, to improve medication utilization.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Discharge medication counseling from a pharmacist
Patient will be educated about proper dosing instructions, potential side effects, and when to recontact the treating physician office.
Home medication if needed
Patient will be provided with medication to take home, when needed.
Follow-up visit at Medication Therapy Management clinic
This comprehensive Medication Therapy Management clinic follow-up visit is scheduled for 7 days post hospital discharge. The approximately 1 hour visit is scheduled with a pharmacist to review current drug therapy and make recommendations, if needed, to improve medication utilization.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Enroll in study prior to hospital discharge.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Providence Health & Services
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laura Hoekstra, Pharm.D.
Role: PRINCIPAL_INVESTIGATOR
Providence St. Peter Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Providence Centralia Hospital
Centralia, Washington, United States
Providence St. Peter Hospital
Olympia, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PSPH-002-Pharm
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.